| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/29/2005 | US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/29/2005 | US6872537 Assays for the detection of microtubule depolymerization inhibitors |
| 03/29/2005 | CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/29/2005 | CA2108699C Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
| 03/29/2005 | CA2099619C Nucleotide sequences of soybean acyl-acp thioesterase genes |
| 03/29/2005 | CA2072023C Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for theses polypeptides, and their preparation and use |
| 03/29/2005 | CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/26/2005 | CA2441695A1 Regulation of matrix metalloproteinases by psp94 family members |
| 03/24/2005 | WO2005026718A1 Stem cell libraries |
| 03/24/2005 | WO2005026392A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 03/24/2005 | WO2005026375A2 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/24/2005 | WO2005026368A2 Dihydroflavonol-4-reductase |
| 03/24/2005 | WO2005026365A1 A thermophilic host-vector system |
| 03/24/2005 | WO2005026364A1 Selection system containing non-antibiotic resistance selection marker |
| 03/24/2005 | WO2005026341A2 Plasminogen activators having reduced lysine binding capacity |
| 03/24/2005 | WO2005026340A1 Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity |
| 03/24/2005 | WO2005026339A1 An nadh dependent l-xylulose reductase |
| 03/24/2005 | WO2005026338A1 Alcohol dehydrogenases with increased solvent and temperature stability |
| 03/24/2005 | WO2005026327A2 Biosynthetic gene cluster for leptomycins |
| 03/24/2005 | WO2005026269A1 Microorganism coating components, coatings, and coated surfaces |
| 03/24/2005 | WO2005026196A2 Methods for folding proteins and reducing protein aggregation |
| 03/24/2005 | WO2005025610A1 Use of markk or markk antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of mark or tau protein |
| 03/24/2005 | WO2005025602A1 METHODS FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C-EPSILON (PKCϵ) AND METHOD OF TREATMENT OF ABERRANT GLUCOSE METABOLISM ASSOCIATED THEREWITH |
| 03/24/2005 | WO2004113519A3 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 03/24/2005 | WO2004112843A3 Odor control compositions and methods |
| 03/24/2005 | WO2004101766A3 Grp94-based compositions and methods of use thereof |
| 03/24/2005 | WO2004081171A3 Variants of enzymes of the alpha-amylase family |
| 03/24/2005 | WO2004065592A3 The crystal structure of a catalytically active portion of a set 7/9 histone methyltransferase and uses thereof |
| 03/24/2005 | WO2004065540A3 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 03/24/2005 | WO2004053142A3 P53-associated parkin-like cytoplasmic protein, and related compositions and methods |
| 03/24/2005 | WO2004047746A3 Regulation of stearoyl-coa desaturase to treat obesity |
| 03/24/2005 | WO2004046336A8 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 03/24/2005 | WO2004043981A3 Nucleic acids and proteins with thioredoxin reductase activity |
| 03/24/2005 | WO2004020637A8 Flavonoid 3',5'hydroxylase gene sequences and uses therefor |
| 03/24/2005 | WO2004012683A9 Novel druggable regions in set domain proteins and methods of using the same |
| 03/24/2005 | WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 03/24/2005 | WO2003087301A8 Methods and compositions for dna manipulation |
| 03/24/2005 | WO2003072746A3 Subtilisin carlsberg proteins with reduced immunogenicity |
| 03/24/2005 | WO2003062380A3 Multiply-substituted protease variants |
| 03/24/2005 | US20050066396 Casein kinase stress-related polypeptides and methods of use in plants |
| 03/24/2005 | US20050066391 Methods of producing nucleic acids coding for proteins have raffinose synthase activity |
| 03/24/2005 | US20050066390 Nucleotide sequences of a new class of diverged delta-9 stearoyl-ACP desaturase genes |
| 03/24/2005 | US20050066381 Transgenic mouse comprising modified gene sequences associated with protein kinase c expression for use as tool in identifying modulator for treatment and prevention of cardiovascular and cardiomyopathic disorders |
| 03/24/2005 | US20050066376 Genetic manipulation method |
| 03/24/2005 | US20050065334 Novel human proteases and polynucleotides encoding the same |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065092 Method of treating obesity and metabolic disorders related to excess adipose tissue by administration of natriuretic peptide receptor C inhibitors |
| 03/24/2005 | US20050065076 Gamma three protease |
| 03/24/2005 | US20050065063 Supercritical fluids processing: preparation of protein microparticles and their stabilisation |
| 03/24/2005 | US20050064592 Cell extract for cell-free protein synthesis and process for producing the same |
| 03/24/2005 | US20050064574 Expression vector comprising nucleotide sequences coding lytic enzyme for use as gene transfer tool in generating transgenic lactobacillus with enhanced amylase activity; improving digestibility of animal feeds |
| 03/24/2005 | US20050064573 Using aspartic protease mixture to deactivate amylase; for use in preparation of dairy products |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064571 Transglutaminase |
| 03/24/2005 | US20050064570 Whole cell catalyst which expresses lactobacillus oxidase for use in generating/producing chrial enantiomer-enriched organic compounds |
| 03/24/2005 | US20050064569 Enzymatic polypeptide which is functionally active in presence of ethyl 4-chloroacetoacetate for use in regenerating coenzymes in an enzymatic reduction system; cyclic generation of preferential compounds |
| 03/24/2005 | US20050064565 Polyhydroxybutyrate polymerase |
| 03/24/2005 | US20050064559 Beta1,3-galactosyltransferase and DNA encoding the same |
| 03/24/2005 | US20050064557 Method for producing proteins |
| 03/24/2005 | US20050064552 Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
| 03/24/2005 | US20050064551 Nucleotide sequences which code for the metY gene |
| 03/24/2005 | US20050064550 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. Jejuni |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064542 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064495 Genetic typing of the human cytochrome P450 2A6 gene and related methods |
| 03/24/2005 | US20050064474 Cleaving cellular chromatin and inserting expression vector comprising nucleotide sequences coding zinc finger-cleavage half domain genetic exchange; genome engineering and homologous recombination |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064439 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 03/24/2005 | US20050064433 Method for cloning and expression of sbfi restriction endonuclease and sbfi methylase in e.coli |
| 03/24/2005 | US20050064411 Diagnostic probe for identifying ubiquitin ligase (NEDl-1) profile for use as diagnostic and prognostic indicator of cell proliferative disorders of nervous system |
| 03/24/2005 | US20050064409 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/24/2005 | US20050064407 Bcl-2 dnazymes |
| 03/24/2005 | US20050064403 Novel Genes Encoding Novel Proteolytic Enzymes |
| 03/24/2005 | US20050064398 Primers for use in detecting beta-lactamases |
| 03/24/2005 | US20050064386 Identification of toxin-binding protein involved in resistance to Cry1 toxins, and related screening methods |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | US20050063974 Detecting expression of a tyrosine threonine kinase-encoding polynucleotide in order to assess prognosis of colon or breast cancer |
| 03/24/2005 | DE102004028302A1 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 03/24/2005 | DE102004028300A1 Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind Stimulation of the activity of an isoform of the lysyl oxidase for controlling some pathologies which are caused by an incomplete, missing or disorganized elastogenesis |
| 03/24/2005 | CA2539132A1 Methods for identifying modulators of protein kinase c-epsilon (pkc.epsilon.) and method of treatment of aberrant glucose metabolism associated therewith |
| 03/24/2005 | CA2538514A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 03/24/2005 | CA2538450A1 An nadh dependent l-xylulose reductase |
| 03/24/2005 | CA2538314A1 Dihydroflavonol-4-reductase |
| 03/24/2005 | CA2537696A1 Plasminogen activators having a reduced capacity to bind lysine |
| 03/24/2005 | CA2535710A1 Alcohol dehydrogenases with increased solvent and temperature stability |
| 03/24/2005 | CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1516928A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 03/23/2005 | EP1516927A1 Method for cloning and expression of SbfI restriction endonuclease and SbfI methylase in E. coli |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1516063A2 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 03/23/2005 | EP1516060A1 Process for producing carotenoids |
| 03/23/2005 | EP1516059A2 Method for the production of sulphur-containing fine chemicals by fermentation |
| 03/23/2005 | EP1516056A2 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
| 03/23/2005 | EP1516053A2 Xylanases, nucleic adics encoding them and methods for making and using them |
| 03/23/2005 | EP1516051A2 Intron double stranded rna constructs and uses thereof |
| 03/23/2005 | EP1516048A2 Protein glycosylation modification in pichia pastoris |